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Non-Photic Mechanisms of Entrainment in BMAL1 Deficient Conditions
Jamie Tran, B.A.
Advisory Professor: Dr. Kristin Eckel-Mahan, Ph.D.

Maintaining our internal circadian (i.e. 24 -hour) clock is imperative to our
daily biological and mental well-being. Large epidemiological studies have shown
that disruptions of our circadian rhythms can lead to poor mental health,
metabolic diseases, and various types of cancer. Various external cues that have
become a part of the modern times such as electricity, shift -work, rapid travel
across various time zones, easier access to nutritionally unbalanced food items,
and various rigid social demands have deleterious effects on our internal clock,
and generally reduce robustness of the circadian clock.
The two following projects aim to examine two fundamental aspects of the
circadian clock mechanism in health and disease: 1) exercise as an entrainment
mechanism for the clock; and 2) targeting of clock proteins to reduce proliferation
and survival in acute myeloid leukemia. Both projects center on the important
role of the circadian clock protein brain and muscle ARNT-like factor (BMAL1),
which is a transcription factor critical for maintaining cellular rhythmicity. Loss of
the protein in the PVN of the hypothalamus can lead to arrhythmicity, but can be
rescued by exercise. In the case of acute myeloid leukemia, this protein can be
targeted to slow the proliferation of transformed cells.
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Together, these data suggest that the exploitation of circadian mechanisms of
entrainment and molecular targeting can be used to rescue the damage inflicted
by circadian disruption.
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Introduction
Mounting epidemiological evidence this past decade has shown that ill-timed or
blunted biological rhythms can have deleterious effects on our physical and mental wellbeing on a systemic level. For example, according to the US Bureau of Labor Statistics in
2019, approximately 2.3 million people out of our nation’s 14.4 million worked on night,
early morning, or rotating shift schedules (United States Bureau of Labor Statistics, 2019)
placing them at high risk for both long and short-term consequences of constant circadian
misalignment and disruptions resulting in systemic consequences such as increased
disruptions to metabolic health, propensity towards certain cancers, negative impacts on
mental well-being and heart problems compared to their non-shift work counterparts
(James, 2017). These negative effects on our overall health are well beyond the scope of
what is given in this thesis and we have yet to gain a full understanding of the depth and
breadth of the consequences we now face. Given that a large percentage of our population
is at risk for such wide-spread effects of circadian disruption, it is of utmost importance to
find ways for us to biologically adapt to our ever-changing modern environment.
Thus, finding new and innovative ways to maintain our internal clock is imperative to
our daily biological and mental well-being. As our society manages to advance
technologically, our bodies become ill equipped to adjust its internal time due to various and
constant external cues and disruptions that have become a part of the modern times such
as electricity, shift-work, rapid travel across various time zones, easier access to nutritionally
unbalanced food items, and various rigid social demands that further damage our own
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rhythmicity. Therefore, it is imperative that alternate, non-photic means of adjusting and
strengthening our internal clocks are of utmost importance to study.
Circadian rhythms are highly conserved molecular mechanisms which are present
throughout the majority of living organisms including single celled bacteria to complex
multicellular organisms. This mechanism serves an important evolutionary role in survival by
allowing organisms to adapt to the 24-hr. environment using environmental cues (also
known as “zeitgebers”). This “entrainment” to the 24-hr. environment allows alignment
between an internal biological 24-hr. cellular clock and coordinate corresponding behavioral
output for optimal success in a variety of behavioral functions. Such adaptation is necessary
for a variety of physiological functions, including: 1) finding or conserving energy resources;
2) predatory detection and avoidance; 3) reproduction; and 4) sleep, among others. In order
for a biological rhythm to be established as circadian, it must fulfill three requirements: A)
have an inherent, near 24-hour periodicity, B) be robust in its oscillation in the face of
inherent biological changes such as temperature (known as “temperature compensation”),
and C) possess the ability to be tuned to a 24-hour period through environmental cues
(otherwise known as entrainment) (Paranjpe & Sharma, 2005).
For most organisms, including humans, the primary means of entrainment to the 24hr. the environment is light. This entrainment pathway begins when environmental input is
received by way of sunlight which enters the eyes and hits the photosensitive retinal
ganglion cells which then convert that light into electrical signals that travel down the retinal
hypothalamic tract to the suprachiasmatic nucleus (SCN) located in the anterior portion of
the hypothalamus (Bass & Takahashi, 2010). The SCN, initially referred to as the “master
2

pacemaker”, then relays this information to other brain areas and peripheral nervous system
to synchronize all of our internal clocks to the light signal. Lesions of the SCN in rodents have
demonstrated the importance of this region in circadian time-keeping; loss of SCN function
results in arrhythmic energy intake, drinking, melatonin secretion, and the sleep/wake cycle
(Bass & Takahashi, 2010).
From a micro perspective, the circadian molecular clock is ultimately functional at
the cellular level (Patke, 2020), where it is composed of specific genetic components
involving a translational-transcriptional feedback loop with the core loop being composed of
core clock genes Bmal1(Brain and Muscle ARNT-Like 1), Clock 1/2 (Circadian Locomotor
Output Cycles Kaput), Period 1/2/3, Cry 1/2 (Cryptochrome), and their respective protein
products. The core loop involves the heterodimerization of two transcription factors, BMAL1
and CLOCK, which together bind to DNA consensus elements known as “E boxes” (CACGTG)
to promote the transcription of other core clock genes, notably period (Per) and
cryptochrome (Cry) in respect to the core loop. PER and CRY will accumulate and ultimately
interact directly with CLOCK: BMAL1 to and inhibit the further transcriptional activity of the
BMAL1: CLOCK transcriptional complex. The PER/CRY proteins will eventually degrade over
time allowing the BMAL1 and CLOCK proteins to build up again, allowing further
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heterodimerization and transcriptional activation at target genes.
Fig. 1 The basic core
transcriptional feedback
loop of the circadian clock.
Transcription factors bind to
E box response elements in
gene upstream regulatory
regions to activate or
deactivate a gene.

Fig. 1

Fig. 2

Fig. 2 Proteins involved in the core clock loop.
is a simplified diagram of the core loop of the
molecular clock depicting the rise of activity in
the transcription factors CLOCK: BMAL1and
the fall of their activity by their transcriptional
targets, the CRY: PER proteins.

In addition to core clock genes, this heterodimer regulates the rhythmic expression
of hundreds of genes in the genome across mammalian organisms. This basic
transcriptional/translational feedback loop is approximately 24 hours and allows for our
bodies to keep their internal time independent of light. Having an ingrained and robust
molecular clock allows cells to function and keep biological time stable within the organism
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and works as an advantage to the benefit of each organism. It achieves this through
signaling the optimal times for each biological system or tissue to function and respond
according to its needs.
Although light may be the primary zeitgeber for the majority of living species on
earth, there are other mechanisms of non-photic entrainment, which have been more
recently appreciated and studied. There are zeitgebers that can overcome the light-driven
time-keeping system of the SCN. For example, even in the absence of light, robust internal
circadian rhythms can still persist. Examples of such extreme conditions and circumstances
in which traditional light signals are not applicable are extremophiles such as cave fish
(Cavallari, 2011), reindeer (Arnold, 2018) and other animals that live near the poles,
organisms that hibernate, and people who have lost their ability to detect light due to
degradation or injury to retinas (Quera Salva, 2017). Although some of these organisms and
situations do not utilize light signals in a traditional manner when it comes to circadian
synchronization, they do have other mechanisms and ways in which to process and express
these signals such as seasonal clock oscillations within reindeer (Arnold, 2018) and dermal
opsins to maintain skin health (Suh, 2020). These organisms and special conditions
demonstrate the importance and mystery of other zeitgebers in which it is necessary to rely
upon an alternate means of entrainment.
Instead of being reliant upon the sun and the resources that wax and wane due to
our earth’s daily and seasonal cycles, modern day technology has enabled us to achieve
extraordinary things such as the invention of electricity and its accompanying technological
gadgets, neigh limitless access to various foods of varying nutritional value, and with that,
5

our society’s fast paced expectations due to these modern-day inventions. Being exposed to
light at inappropriate times in the day, having the ability to eat anything at any given time,
rapid travel across time zones, and lack of social boundaries (such as working night shift or
odd hours, constant access to instant communication, etc.) that often accompanies artificial
light exposure creates many opportunities for our circadian rhythms to become more
atypical or blunted easily and for a longer period of time impacting or leading to various
disease states such as disrupted sleep, affective disorders, metabolic disorders, and even
certain forms of cancer.
Energy intake in particular has gained research momentum in the last decade as an
alternate means of entrainment. Specifically, altered energy intake patterns or nutrient
challenge with or without changes in the temporal aspects of energy intake can dramatically
alter the circadian clock in a tissue-specific way (Dyar, 2018). One such example is the liver
clock. A high fat diet easily results in fatty liver, and results in a dramatic circadian
reprogramming of gene expression, to drive fatty acid storage in the liver (Eckel-Mahan,
2013). Fatty liver is now known to be a risk factor for hepatocellular carcinoma of the liver
(Fekry, 2019).
To better understand the protective role of the circadian clock in the body, I have
undertaken two projects during my master’s thesis, both of which rely on a better
understanding of the transcription factor BMAL1 in cells and tissues of the body. While both
projects center on the important role of the clock through BMAL1, both projects also focus
on circadian rhythm restoration through non-photic means in different cell types.
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The first project focuses on the loss of BMAL1 in the paraventricular nucleus (PVN),
its metabolic and behavioral effects following that loss, the ability of exercise to restore
rhythmic behavior, and the magnitude of its effect. This project will address two issues: a)
that circadian behavioral output does not solely depend upon the suprachiasmatic nucleus
(SCN) and b) that exercise can overcome arrhythmic disruption in the PVN. I hypothesized
that loss of rhythmicity by BMAL1 deletion in the PVN could be restored using exercise as a
Zeitgeber.
The PVN is an area of the brain that is of particular interest to energy balance due to
its ability to process information regarding energy intake and expenditure. Interestingly,
recent studies (Kim, 2020) demonstrate that BMAL1 expression in the PVN is necessary for
driving dramatic changes in circadian behavior. Specifically, previous data has shown that
loss of BMAL1 in this area leads to inappropriate energy intake during various hours of the
day resulting in obesity (Kim, 2020). This study gave insight into the novel idea of the PVN
having an independent influence on circadian behavioral output and suggests that the SCN
is not the only area to influence rhythmic behavioral outcomes.
Though light and energy intake are potent zeitgebers, in recent years, both
modifications to energy intake and expenditure have been proven to drive dramatic changes
in rhythmicity across many peripheral tissues. This particular pathway to entrainment differs
from the conventional light entrainment pathway in the fact that it uses humoral
information (such as nutrient signals) garnered from the paraventricular nucleus (PVN) to
modulate the body’s circadian rhythm instead of the light information gained from the
retinohypothalamic tract (RHT). Although it has been known for quite some time that
7

environmental cues other than light are able to entrain and regulate circadian rhythms, the
strength and permanence of these entrainment methods and the mechanisms in which it is
able to do so are not well understood. In particular, exercise as a means to sync and restore
circadian rhythmicity has been gaining momentum as a potential therapeutic strategy in the
fields of mental illness and metabolic diseases. For example, the Pendergast lab has
reported that exercise can induce a phase shift in humans according to their chronotype
(Thomas, 2020) providing insight as to how exercise can entrain people of varying circadian
rhythms. On a molecular level, the Colwell Lab has found that exercise has the ability alter
circadian rhythms on a genetic level in wild type and vasoactive intestinal peptide deficient
mice (Schroeder, 2012). Even though these studies have provided great insight into
rhythmicity restoration, their studies still have the PVN intact in their models which is in
contrast to the Tong Lab’s results of aberrant circadian locomotor patterns via BMAL1
depletion in the PVN with an intact SCN (Kim, 2020).
To address this discrepancy, we intend to use exercise as a therapeutic strategy to
restore circadian rhythmicity using PVN damaged mice. Two different mice models will be
used to assess circadian behavior using actograms to reflect sleep/wake cycles with and
without the inclusion of the exercise wheel. These wheels will then be taken away to assess
the permanence and magnitude of rhythmicity restoration. This objective will address two
issues: a) that circadian behavioral output does not solely depend upon the SCN and b) that
exercise can overcome arrhythmic disruption in the PVN.
My second project centers on understanding whether pharmacologically modulating
BMAL1 expression via a natural flavonoid, “nobiletin” (NOB) in low BMAL1-expressing acute
8

myeloid leukemia (AML) cells is a tractable mechanism with or without existing
chemotherapeutic agents for slowing the growth of AML. AML is one of the most difficult
cancers to treat due to it being an integral part of the circulatory system, its heterogeneity,
and aggressive nature. One of the most common treatments for AML is daunorubicin (DNR).
It works by interfering with DNA base pairs and causing the helix to uncoil, thus inhibiting
DNA replication in the S phase of the cell cycle. However, this effect is not cell specific and
can also damage healthy cells as well, causing complications in treating patients (Alves,
2017). Because of these detrimental off-target effects, there is a dire need for a safer
administration of DNR in order to treat patients while limiting harm. With this idea in mind,
this project seeks to use nobiletin as a pharmacological additive to use in conjunction with
traditional chemotherapy. It operates by directly agonizing Retinoic Acid Receptor-Related
Orphan Receptor Alpha (RORɑ), a transcription factor which activates the circadian protein
BMAL1 (Chen, 2018). This in turn, activates apoptotic signals downstream to kill cancer cells
while leaving healthy cells unharmed (Chen, 2016; Lellupitiyage, 2020). The overall goal of
this project is to use NOB in conjunction with traditional daunorubicin to lower the amount
of DNR being used to decrease toxic off target effects whilst maintaining apoptotic efficacy
in AML. Based on previous data using liver cancer and glioblastoma cells using NOB as a
therapeutic reagent (Mahan Lab, unpublished data), I hypothesized that modulating BMAL1
in AML might further slow the growth of AML in combination with standard
chemotherapeutic agents.
Ultimately, both projects will hopefully help lay a foundation for future studies,
including clinical potential in chronobiology and both are worth exploring as an alternate
9

means of restoring or strengthening circadian rhythmicity. While pharmacological
modulation of the clock is an area of active study, behavioral mechanisms (such as timerestricted feeding) are additional mechanisms by which the circadian clock can be fortified
in the body. This is also a feasible clinical approach, and there remains hope that targeting
the clock may be an important therapeutic strategy for the future in the context of a
number of disease states.
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Results
Exercise as a Potential Therapeutic Strategy for Circadian Disruption in the Paraventricular
Nucleus
Characterizing PVN specific, BMAL1-depleted Knockout Mice
In addition to the initial metabolic characterization of the PVN specific, BMAL1deficiency reinforces that circadian behavioral output is not entirely dependent on the SCN.
Previous data from the Tong lab suggested that loss of PVN rhythms may drive arrhythmicity
independent of the SCN (Kim, 2020), a property that was thought to be driven
predominantly by arrhythmicity in energy intake (Izumo, 2014). In further characterizing
these mice it was determined whether or not SCN rhythms were still intact in mice in which
BMAL1 had been disrupted.

Fig.3

Fig. 3 Mouse model of BMAL1 deletion in the PVN. PVN-specific knockout of BMAL1 is achieved through the viral
injection of AAV-CRE-GFP into BMAL1 mice having loxP sites surrounding the Bmal1 gene. Control animals are injected
with AAV-GFP.

The circadian molecular clock in the PVN was depleted by using BMAL1 fl/fl mice
(Jackson Laboratories, #007668) generated by the CRE-Lox method to create a conditional
knockout model. At 8 weeks old, these mice were subject to bilateral intracranial injections
of either an AAV-CRE-GFP virus to knock out BMAL1 in the PVN or AAV-GFP for control
groups (Kim, 2020). These mice were then put under surgical care observation for the first
three days in 12-hour light/12-hour dark entrainment conditions to ensure proper healing
11

and then further monitored by infrared sensors (Starr Life Sciences) detecting movement for
the duration of two weeks in order to define behavioral phenotype of rhythmic, arrhythmic
or weakly rhythmic circadian locomotion.

Fig. 4a

Fig. 4c

Fig. 4b

Fig. 4d
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Fig. 4e

Fig. 4f

Fig. 4 Representative AAV-GFP (control) animal. A side-by-side comparison of actograms and their representative
periodograms of an AAV-GFP injected animal over a period of three months. On the left (Fig. 4a, 4c, 4e) are its
actograms recorded via infrared sensor with black ticks indicating activity or movement. On the right (4b, 4d, 4f) are
their respective periodograms indicating the average number of hours it takes for the animal’s period to cycle through
and the strength of its period.

Activity was recorded using the Vital View data collection system and analyzed with
Clock Labs (Actimetrics, version 6) in order to generate actograms (a visual representation of
locomotor activity indicated by a dark tally for movement) and periodograms (used to depict
the length and strength of an organism’s underlying biological rhythm) to analyze the
duration and level of activity. Represented above in Fig. 4a-4f is a representative actogram
of a control mouse (n=2) demonstrating a 24-hour periodicity and heightened activity during
the 12-hour night dark phase and decreased activity levels during the 12-hour day phase
with a clear distinction between both day and night.
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Fig. 5a

Fig. 5b

Fig. 5 Representative AAV-CRE (PVN BMAL1 KO) animal, pre-exercise. The figures above represent the PVN-BMAL1 KO
animal’s actogram (5a) and periodogram (5b) before starting exercise.

While control mice (GFP only) show strong rhythmicity similar to a WT mouse
without virus injection, CRE-injected mice show a drastically different phenotype. The
BMAL1-deficient PVN mouse displayed elevated erratic locomotor activity during its first
two-week post-injection, with no distinct patterns of rest between night and day (Fig. 5a5b). Though the periodogram suggests some rhythmicity in the CRE-injected mice, notice
the scale bar is vastly different than the control, suggesting that the mouse is weakly
rhythmic compared to the GFP-only injected mouse.

Fig. 6a

Fig. 6b
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Fig. 6c

Fig. 6e

Fig. 6d

Fig. 6f

Fig. 6 Actograms and periodicity of a PVN BMAL1-deficient animal (M8) recorded over a duration of three months. Weeks 1-2 were preexercise in order to fully characterize the animal as having an arrhythmic behavioral phenotype. Weeks 3-6 were when the animal was given
free access to the running wheel. After week 7, the running wheels were taken away to assess the permanence of their circadian rhythmicity.
On the left are the actograms measured via infrared sensor (Fig. 6a, 6c, 6e) and their respective periodograms (Fig. 6b, 6d, 6f).

However, when presented with the opportunity to exercise via wheel running, the
knockout mice chose to run rhythmically, and their rhythmicity was retained even after the
wheel was taken away (Fig. 6a-6f). This information suggests that effects of entrainment are
rapid with the animal choosing to run rhythmically on the same day that the wheel was
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presented, that entrainment persists with the wheel, and that the effects of entrainment are
permanent after the wheel is taken away.

Fig. 7a

Fig. 7c

Fig. 7b

Fig. 7d

Fig. 7 Actograms and periodicity of PVN-deficient BMAL1 knockout mice. Activity (A) and period length (b) of a PVN, BMAL1deficient mouse (M8) and activity (c) and periodicity (D) of another PVN BMAL1-deficient (M12). Both animals were initially recorded
for two weeks to establish arrhythmicity.

In observing their circadian profiles, actograms were generated between the two
knockout mice. The M12 actogram reveals that circadian activity is not completely
arrhythmic but can be more specifically defined as weakly rhythmic with a blunted
periodicity of 24 hours. However, based on the periodograms, it appears to be improved by
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wheel running, an improvement which persists even when measured by infrared sensor (Fig.
8a-8c).

Fig. 8a

Fig. 8b

Fig. 8c

Fig. 8d

Fig. 8 Actograms and periodicity of a PVN BMAL1-deficient animal (M12) recorded over a duration of three months. Weeks
1-2 were pre-exercise in order to fully characterize the animal as having an arrhythmic behavioral phenotype. Weeks 3-6 were
when the animal was given free access to the running wheel. After week 7, the running wheels were taken away to assess the
permeance of their circadian rhythmicity. On the left are the actograms measured via infrared sensor (Fig. 8a, 8c, 8e) and their
respective periodograms (Fig. 8b, 8d, 8f).

In contrast, the activity of M8, is completely arrhythmic, with high activity at all
times with no distinct circadian patterns of rest and activity between light and dark. There is
17

clear rescue by the wheel, which is also maintained when the wheel is removed. Likewise,
the relationship between arrhythmicity and body weight regulation is not yet clear (See Fig.
9). Though M8 was initially more arrhythmic, its body weight did not increase to the extent
that M12 did. Analysis of more mice will reveal the extent to which BMAL1 loss in the PVN
accelerates obesity independent of rhythmicity. Though previous reports demonstrate that
loss of BMAL1 in the PVN does result in obesity, these experiments were not done with
wheel runners. The enhanced energy expenditure induced by the wheel runners may alter
energy balance such that the obesity phenotype is more variable from mouse to mouse
depending on the energy expenditure for each mouse.

Fig. 9

Fig. 9 Body weight progression of PVN BMAL1-deficient mice. Weight progression of two different PVN
BMAL1-deficient mice at progressive weeks following BMAL1 loss.

Restoration of Circadian Locomotor Activity
Once an animal was experimentally defined as arrhythmic or weakly rhythmic,
animals were voluntarily placed on exercise wheels in 12hr light/12hr dark conditions for an
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additional two weeks to determine whether rhythmicity would be able to be restored or
strengthened by exercise. The wheels were then removed from the cage and animals were
monitored on IR for an additional month to assess the permanence of rhythmicity
restoration or strengthening.

Fig. 10a

Fig. 10b

Fig. 10 Activity levels of control and PVN BMAL1-deficient mice. Overall activity of mice injected with GFP virus or GFP-CRE
virus (a). Exercise-only quantified in control vs. PVN BMAL1-deficient mice (b).

Fig. 11

Fig. 11 Percent of total daily activity for control and PVN BMAL1-deficient mice in each behavioral condition.
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As shown, control animals tend to be closely matched together in all three
conditions and display very little variation between each other and throughout the different
conditions. However, for both knockout animals, it was only M8 that displayed the most
significant amount of decreased activity during its rest period and was sustained postexercise. However, with M12, while there was improvement in decrease of movement
during their rest phase in the exercise condition as soon as the wheel was taken away its
activity levels during the day and night returned to that of the pre-exercise condition. An
interesting thing to note is that the amount of activity during their rest period was
significantly improved during and post exercise for all conditions and heightened during
their active period with voluntary wheel running which may indicate that exercise may aid in
sustaining sleep. For the post-exercise condition, all animals sustained a consistent level of
exercise during their active period and their rest period. These two observations suggest
that circadian rhythmicity may be improved during both the active and rest periods via sleep
maintenance.

Fig.12
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Fig. 12 Body weight progression of both control and PVN BMAL1-deficient mice. Weight progression of all animals
over three months following injections, exercise, and post exercise conditions.

Currently we cannot explain these differences in energy expenditure, though it may
reflect a difference in overall BMAL1 expression remaining in the PVN. Though target sites of
injection were validated by immunohistochemistry, we cannot currently rule out off target
effects that are not picked up by protein validation. Nevertheless, this experiment supports
the strong role of exercise in clock re-entrainment, which remarkably, can persist even when
its zeitgeber of exercise is removed. This is the first demonstration of exercise-induced reentrainment in the BMAL1-deficient PVN model.
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The Synergistic Effects of Nobiletin and Daunorubicin in AML Viability
Like metabolic disease, cancer has been linked to circadian disruption in humans
(Fekry & Eckel-Mahan, 2022). The molecular basis for this is not entirely clear. However
several of the core circadian clock genes have been demonstrated to play a role in cancer
prevention (Jiang, 2017; Fu, 2002; Zhang, 2020). For example, circadian gene period 2 is
heavily implicated in tumor suppression and is critical for cell cycle control and homeostasis
(Fu, 2002; Wang, 2020; Zhang, 2020). Loss of PER2 increases irradiation-induced
mutagenesis (Fu, 2002). When absent, thymocytes are prone to unregulated cell growth
and proliferation and a decreased sensitivity to p53 apoptotic signaling (Fu, 2002).
Interestingly, our laboratory has shown that in the context of some cancers, BMAL1
expression is quite heterogeneous. In liver cancer, for example, BMAL1 gets completely lost
in some tumors (repressed by a fetal isoform of hepatocyte nuclear factor four alpha), while
in some tumors BMAL1 is very highly expressed and hepatocyte nuclear factor four alpha
expression is lost altogether (Fekry, 2018). Treatment of BMAL1-deficient tumors with the
compound nobiletin can cause cell death and apoptosis (Lellupitiyage, 2020). NOB is a
compound that targets the circadian molecular clock by directly agonizing Retinoic Acid
Receptor-Related Orphan Receptor Alpha (RORɑ), a transcription factor which activates the
circadian protein BMAL1 (He, 2016) We have observed similar heterogeneity in BMAL1
expression in Acute Myeloid Leukemia (AML) cell lines and have been employing a similar
strategy of NOB treatment to better understand whether pharmacological targeting of NOB
can reduce proliferation and viability in AML. Preliminary data suggests that this natural
flavonoid and activator of the circadian system, might be an ideal reagent to use in
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combination with DNR to improve AML response. Because standard chemotherapy for AML
involves cardiotoxicity (Alves, 2017), we have been using NOB alone and in combination
with daunorubicin, to see if there might be additive or synergistic effects of these
compounds which could potentially allow for daunorubicin to be used at a lower dosage so
as to limit toxicity. Though NOB appears to induce apoptosis and cellular arrest in AML cells,
it has minimal to no toxic side effects in conjunction with DNR in non-cancerous cells.
Similar findings have been found in metabolic studies, where NOB administration to wildtype mice shows negligible side effects, and even combats metabolic disease in the context
of diet-induced obesity (Lee, 2013). In fact, NOB can enhance healthy aging, though not
extending the lifespan of laboratory mice (Kazunari, 2019).
For this project, in vitro approaches using several AML cell lines have been used to
assess the synergistic strength of NOB and DNR in eliminating AML cells whilst reducing the
cardiotoxic off-target effects of DNR required for AML cell death. In doing so, we will
determine the minimum amount of DNR to be used in conjunction with NOB to achieve
successful elimination of these cells as well as determine the effectiveness of modulating
the clock for viability and proliferation of several AML cell lines.

Characterizing the Molecular Clock in Acute Myeloid Leukemia
Due to the heterogeneity of AML, several cell lines were selected to represent the
different cell states of AML. Represented below (Fig. 13) are cell lines THP-1 (ATCC, Catalog
#: TIB-202), Kasumi-1 (ATCC, Catalog #: CRL-2724), MOLM13 (DSMZ, Catalog #: ACC 554),
and MV411 (ATCC, Catalog #: CRL-9591). Each of these lines were probed for inherent levels
23

of BMAL1. Treatment of 25nM of DNR, 10μM of NOB, and a combination of both reagents
was then applied to low BMAL1 expressing lines MOLM13 and MV411 with varying levels of
success in killing cells (Fig. 14).

Fig. 13

Fig. 14

Fig. 13 Endogenous protein
levels of representative AML
cell lines THP-1, MV411,
Kasumi-1, and MOLM13.
Actin was used as a loading
control for each cell line.

Fig. 14 Dose response analysis of compounds in all cell lines. Absorbance
reflects cell viability of cells treated with 25nM of DNR, 10μM of NOB, or a
combination of both reagents.
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Optimizing Treatments
With the varying responses to the combined treatment of DNR and NOB, it was
decided that an IC50 approach was necessary for optimization of the treatment for each cell
line. I performed IC50s for both NOB and DNR, and specific doses were chosen for each cell
line to ensure the minimal amount of DNR to assess the synergetic effect of NOB in killing
cells. After the combined doses were chosen and evaluated via MTT assay, western blots
were used to investigate BMAL1 and Cleaved Caspase 3 protein levels to assess the level of
NOB influence on downstream apoptotic signaling. These blots were then quantified using
ImageJ and graphed via Microsoft Excel.

Fig. 15a

Fig. 15b

Fig 15 Dose response analysis of compounds in MOLM13 cells. Absorbance reflects cell viability of MOLM13 cells treated
with varying doses of NOB (a) and DNR (b) individually.

Fig 16 Dose response analysis of various
combinations of NOB and DNR in MOLM13. Various
combinations of both NOB and DNR used in order to
evaluate the combination most effective to produce
a synergetic effect.
Fig. 16
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Depicted in Fig. 16 and 17 above are the IC50 results chosen for the cell line
MOLM13 based on minimal amount of DNR and maximal amount of NOB necessary for
killing cells effectively. Ultimately, the dose of 10μM of NOB and 25nM of DNR was deemed
the most optimal for observing the synergistic effects of NOB and DNR with cell death in
MOLM13 cells.

Fig. 17 Cell viability of MOLM13
cells treated with NOB, DAUN, or
both in combination at various
time points after treatment. Live
cell viability was measured via
Trypan Blue in cells treated for 24,
48, or 72 hours with vehicle or
selected reagents.
Fig. 17

26

Fig. 18a

Fig. 18b

Fig. 18 Changes in morphology and proliferation of MOLM 13 cells over time and treatment. Cell
morphology and density of cells plated at day 0 (a). Cell morphology and density of MOLM13 cells
after three days of treatment with no treatment, NOB, DNR, or NOB+DNR (b).

MOLM13 live cells were assessed and quantified through the use of Trypan Blue
(1:100) and BioTek’s Cytation 5 machine on 4x over the span of 72 hours. All cells were
plated at a density of 1x105 cells per well with no treatment (NT), 10μM of NOB, 25nM of
DNR. At zero hours, all cells are at relatively the same health and number per well. However,
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the greatest impact can be seen at 72 hours with the NT displaying the highest proliferation
and health rates and NOB condition having reduced proliferation. DNR-treated cells had no
with additional cell death, and the combined treatment having the most cell death occurs.

Fig. 19a

Fig. 19b

Fig. 19 BMAL1 expression in
MOLM cells treated with
different compounds. BMAL1
levels of MOLM13 in four
conditions: NT (Non-treated),
10μM NOB (Nobiletin), 25nM
DNR (Daunorubicin), and COM
(Combination of NOB and
DNR) with n = 4 for all
conditions (19a). (19b) Overall
quantification of BMAL1 in
MOLM13 normalized to Actin
protein for each condition.

After optimizing treatment levels for MOLM13, cells were grown at 5x10 6 per petri
dish for 72 hours, cells then treated with either no treatment (NT), 10μM of NOB, 25nM of
DNR, or a combination of both NOB and DNR, harvested, and flash frozen via liquid nitrogen
to prepare for protein sample analysis via Western Blot. Depicted above in Fig. 19a-19b are
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the protein levels of BMAL1 that were quantified by ImageJ (n = 4, all conditions). BMAL1
was chosen as an indirect indicator of downstream ROR-alpha activity. The figure depicts the
highest amount of BMAL1 with the combined treatment with the least amount of BMAL1 in
the DNR condition.

Fig. 20a

Fig. 20b

Fig. 20 Dose response analysis of compounds in MV411 cells. Absorbance reflects cell viability of MV411 cells treated with varying
doses of NOB (Fig. 20a) and DNR (Fig. 20b) individually.

After optimizing treatment levels for MV411 (Fig. 20), cells were grown at 5x106 per
petri dish for 72 hours, cells then treated with either no treatment (NT), 25μM of NOB,
10nM of DNR, or a combination of both NOB and DNR harvested, and flash frozen by liquid
nitrogen to prepare for protein sample analysis via Western Blot. Depicted below in Fig. 21a21b are the protein levels of BMAL1 that were quantified by Image J. With this cell line, it
appears that it is more sensitive and gives forth a greater BMAL1 output in both the NOB
and combined conditions. The discrepancy of BMAL1 output in both cell lines could be
attributed to the number of ROR-alpha receptors that are average for each cell line. Other
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factors could include the number of cell passages which could negatively influence BMAL1
and or ROR-alpha expression.

Fig. 21a

Fig. 21b

Fig. 21 BMAL1 expression in MV411 cells
treated with different compounds. BMAL
levels of MV411 in four conditions: NT (Nontreated), NOB (Nobiletin), DNR (Daunorubicin),
and COM (Combination of NOB and DNR) with
n = 4 for all conditions (Fig. 21a). (Fig. 21b)
Overall quantification of BMAL1 in MV411
normalized to Actin protein for each condition.

Due to the variable amounts of BMAL1 expression per cell line, I decided to take a
closer look at RORɑ levels of each one to see a) their basic expression levels without
modification and b) to see if NOB would modify their expression levels.
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Fig. 22

Fig. 23

Fig. 22 BMAL1 and RORα expression in MOLM13
cells. Western blot showing BMAL1 and RORα
expression (top) and quantification of expression
normalized to ACTIN in conditions NT – non-treated
and NOB – nobiletin at time points of 0 hours and 24
hours. RORɑ expression is consistent across both
time and treatment.

Fig. 23 BMAL1 and RORα expression in MV411 cells.
Western blot showing BMAL1 and RORα expression
(top) and quantification of expression normalized to
ACTIN in conditions NT – non-treated and NOB –
nobiletin at time points of 0 hours and 24 hours. RORɑ
expression is consistent across both time and
treatment.
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To our surprise, both MOLM13 and MV411, RORɑ and BMAL1 expression remains
unchanged regardless of time and treatment within each cell line itself (Fig. 23 and 24).
However, in comparing the two cell lines, it appears that they have complementary
expressions compared to one another. While the RORɑ expression in MOLM13 seems to
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elevate after 24 hours, the RORɑ expression in MV411 shows the exact opposite trend by
decreasing RORɑ expressions after 24hours. From these data, it can be concluded that RORɑ
protein expression remains steady within each cell line regardless of treatment with NOB
and time but can vary across various cell lines in RORɑ and BMAL1 upregulation expression
and time for reasons that are potentially independent of RORɑ expression.
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Discussion
Based on the increasing number of studies linking circadian disruption to metabolic
disease, understanding mechanisms by which to target the clock to delay disease onset or
progression is pressing. Collectively, my studies have demonstrated the importance and
strength of specific entrainment mechanisms to bolster circadian rhythms in instances
where light entrainment is not sufficient or applicable. In the case of circadian dampening or
disruption in the hypothalamus, exercise might be one mechanism by which to restore
normal rhythms in vivo. On the other hand, exploiting the clock by altering protein
expression to treat cancer cell growth and progression may be a tractable solution to
limiting toxicity and improving efficacy of specific cancer treatments.
Modern day technology has made us less reliant upon solar cycles by providing
access to light at night. This unregulated accessibility to light can be something as small as
flipping on a cellphone at night to having the ability to expose entire task forces to working
at unconventional hours when our bodies need to be resting. The latter is commonly
referred to as “nightshift work” or “rotating shift work” depending on the specific work
schedule and is a common form of circadian disruption and misalignment. This growing
phenomenon of circadian disruption also extends to future generations and has already
been shown to negatively affect children, putting them at risk for future systemic diseases
that stem from circadian dysfunction (Crowley, S. 2015). Even though we cannot alter
society’s expectations and functions according to what is biologically best for human health,
perhaps a more comprehensive knowledge about the beneficial effects of a stricter
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circadian cycle will enable individuals to understand the value of the clock in their
physiology and health.
Exercise as a Potential Therapeutic Strategy for Circadian Disruption in the Paraventricular
Nucleus
In the context of PVN clock disruption, my data suggests that exercise provides a
much faster and stronger circadian behavioral restoration as compared to their timerestricted feeding cohorts based on both the actograms and periodograms. Although my
number of animals is limiting, both animals demonstrate a strong, exercise-induced
behavioral restoration that persists when the wheels have been taken away. Importantly,
these results imply separate neural circuits and functions for circadian rhythmicity
restoration and metabolism. Interestingly, though both mice gained rhythmicity, one clearly
lost weight and had an improved metabolism while maintaining high activity levels, while
the other continued to gain weight and remained at activity levels closer to the control.
Obviously, more animals are needed, but these results suggest that exercise may be a
tractable solution for promoting more robust rhythmicity in the context of aging or chronic
jet lab, two situations where the clock is thought to be dampened (Leise, 2013; Oneda,
2022).
In the PVN knockout mice, our data demonstrate that exercise has not only powerful
restorative effects on behavioral circadian rhythmicity, but these effects can persist even
when the zeitgeber is removed. These data suggest a major influence of exercise on
circadian locomotion. These studies are also important because they underscore that other
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areas besides the SCN are able to influence locomotor rhythmicity Though published
recently in the context of energy intake (Kim, 2020), my studies demonstrate for the first
time that loss of rhythmicity by PVN deletion of BMAL1 is recoverable, and that exercise is a
stronger zeitgeber for the central clock in this context than light input to the SCN. Prior to
1990, the primary focus for analyzing circadian behavioral output was the SCN (Saper, 2013).
However, in recent times the lens in which we perceive circadian output has been widened
and studied in other contexts besides entire lesions such as cell-specific lesions that involve
eliminating SCN transmission via various neurotransmitters, deletion of several core clock
genes within the SCN itself, or other zeitgebers independent of light that are not dependent
on the SCN at all. Thus, these studies in conjunction with prior results (Kim, 2020)
demonstrate that other areas of the brain such as the PVN may be able to influence overall
circadian locomotion independently of the SCN and give vital information as to how nonphotic circadian entrainment can influence circadian behavior.
As a behavioral phenotype, we saw rapid weight gain within the first two weeks of
injection, arrhythmic eating patterns, and overactive locomotor activity regardless of time of
day. Initially, our lab sought to regain rhythmicity through modifying energy intake via time
restricted feeding (Mahan Lab, unpublished). Although TRF did manage to restore
rhythmicity somewhat, locomotor output was still somewhat fragmented over the 24-hr.
cycle, resulting in a weaker period overall. In addition, TRF mice showed slow entrainment
as seen below, and not until the second week of TRF did animals reveal rhythmicity that was
more similar to the control condition (Fig. 24a-24b).
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Fig. 24a

Fig. 24b

Fig. 24 Time Restricted Feeding (TRF) restoration actograms and periodograms. Above (Fig. 24a) depicts an
actogram (left) and its respective periodogram of a male arrhythmic animal three weeks before starting TRF and 2
weeks during TRF. Below (Fig. 24b) is the actogram and periodogram of the corresponding female animal on the
same paradigm.

With this phenotype and previous experiments in mind, I sought to modulate their
arrhythmic behavior by using a counter metabolic behavior in charge of energy expenditure,
which is exercise. In my experiments, the PVN BMAL1 KO animal model was behaviorally
consistent with previous literature (Kim, 2020), in showing a pronounced effect on
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rhythmicity and whole-body energy balance (Kim, 2020). Exercise as a means of circadian
restoration may have been possible through an intact SCN VIP and VPAC2 signaling through
this loss of BMAL1 since our SCN was intact, but how it connects or if it has the ability to reentrain the PVN still remains a mystery and that connection may be able to be investigated
through observing the neuronal connections and signaling studies between the SCN and
PVN as demonstrated in Dr. Herzog’s lab (Jones, 2021). Although their primary purpose was
to look at how the loss of BMAL1 in CRH neurons affects CORT signaling between these two
regions in the hypothalamus, the data suggests important signaling occurs between the two
regions. According to their findings, there was no neuronal or synaptic strengthening
between these regions when BMAL1 was eliminated, but what was found was an increase in
VPAC2 receptors in the PVN as well as the SCN. These data imply that there were more
receptors of VPAC2 to volumetrically capture VIP signals coming from the SCN, and thus
affecting circadian entrainment. This creates a novel link since literature on exercise and
circadian behavioral output was measured primarily in regards to the SCN and its
connections to peripheral tissue, bypassing the PVN altogether. By interrupting this “inbetween” step, the PVN has its own critical influence on circadian behavior. However, the
precise mechanism and molecular pathway and signaling pathways that mediate this effect
is elusive. There are several ways in which we can investigate the following further.
From a molecular standpoint, it would be insightful to look at a variety of different
molecular inputs and outputs associated with exercise and circadian rhythmicity such as
CORT and VIP which are critical in modulating arousal and can be seen as a possible output
of circadian rhythmicity from the PVN. By comparing them to base levels with and without
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exercise as well as the SCN baselines of VIP and VPAC2 between the two brain regions
before and after exercise one could study how these neuronal populations are affected by
exercise by their molecular expression. Another route of consideration would be to look at
this from the opposite end of the spectrum to see if skeletal muscle could be giving
biochemical feedback to the brain in order to influence or correct arrhythmic behavioral
patterns. Peripheral clocks are known to feed back to the brain to control circadian behavior.
To investigate this particular train of thought, skeletal muscle, the PVN, and the SCN could
be analyzed for changes in metabolite expression after exercise. To address whether muscle
may be producing myokines that might affect brain function, serum might be analyzed for
changes in metabolite content. Finally, retrograde labeling of synapses might reveal
potentially new or changed synaptic connections between the PVN and the SCN.
Lastly, looking at the circadian metabolomics, behavior, and molecular changes
within both the SCN and PVN in both exercise during the early active period and late active
period would be of potential therapeutic benefit. According to a clinical study done by the
Pendergast Lab (Thomas, 2020), exercise in the early morning was able to advance the
phase of people with circadian rhythms of a late chronotype. In addition to that study, the
Sassone-Corsi lab (Sato, 2022) provides strong insight into the metabolic changes and
strength of circadian connections to different systems according to the time that exercise
was performed giving potential to new, non-invasive therapeutic strategies that can target
certain biological systems that are affected by ill synchronized body tissues. The timing and
duration of exercise may be a way to assist individuals either trying to alter their
chronotype, or deal with circadian rhythm disorders.
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Not to be ignored is how feeding and timed exercise can alter circadian metabolic
behaviors because of their hedonic value. For example, methamphetamine has been shown
to re-entrain arrhythmic mice through a poorly defined oscillator known as the
methamphetamine-sensitive circadian oscillator (Tataroglue et al, 2006). This would be a
good area to look at in order to answer how powerful food or exercise would be as a
mechanism of entrainment potentially why modifying energy intake or expenditure may be
so effective. It may also provide insight as to why the animal may be choosing to run
rhythmically during its active period when given free access to the wheel. Other
experiments to see if exercise is rewarding and therefore, a stronger, faster, and more
permanent way of entrainment is comparing not only timed energy intake and voluntary
wheel running, but also to look at forced treadmill vs. voluntary wheel running to see if the
reward pathway is altered along with entrainment or if they would be separate. By doing
this, we can see the extent of how rewarding it is and if exercise, reward, and entrainment
are truly tied together. We could do so by looking at the networks in the SCN, PVN, and the
paraventricular thalamus (PVT) which is involved in reward. Other areas of interest that
could be strengthened to the ties of circadian rhythmicity, metabolism, and reward could be
the subparaventricular zone (SPZ) and dorsal medial hypothalamus (DMH) which are directly
linked to locomotor output via SCN VIP neurons and are also heavily involved in both energy
regulation and circadian rhythms.
And finally, from a systemic point of view careful consideration should be given to
sex differences in core clock gene manipulations and exercise due to the fact that both of
these factors can have profoundly different effects between the two sexes. For instance, in
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the case of BMAL1 depletion within the striatum, the effects of alcoholic preference and
drinking behavior differ between the two sexes of mice (de Zavalia, 2021). When knocked
out in the striatum of these animals, males exhibited a behavioral phenotype of repressed
drinking behavior whilst the females had the exact opposite effect and were more prone to
drinking. In the case of exercise, Dr. Asher’s lab (Adamovich, 2021) found that circadian
rhythms and expressions differed not only according to time dependence, but also between
the sexes according to their paradigm. They found that the exercise capacity between the
two sexes differed in terms of metabolic output and physiological endurance. With female
mice, they were unable to sustain glucose levels for as long as male mice when exercising
during their early active period vs. the late active period as well as having a higher
respiratory exchange rate and caloric intake. Both of these studies highlight the profound
differences between sexes under the same experimental conditions and thus, the absolute
need to account for these differences in future studies.
The Synergetic Effects of Nobiletin and Daunorubicin to Induce Apoptosis in Acute
Myeloid Leukemia
One important finding of this project is the fact that NOB can help induce apoptosis
in low-expressing BMAL1 cancer lines. This finding could have clinical importance because
chemotherapy is usually non-discriminant in killing cells and oftentimes causes toxic offtarget effects to otherwise healthy cells. However, previous studies have supported the fact
that NOB has minimal effects on healthy cells (Huang, 2016; Mahan Lab, unpublished
observations). Because NOB acts as an agonist at RORɑ it may have a unique effect only in
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low BMAL1-expressing cancer cells whilst minimally affecting healthy cells with optimal
levels of BMAL1 alone. NOB is a natural flavonoid (originating from organic compounds such
as citrus peels and is, in general, considered non-toxic to healthy cells). By adding NOB to
traditional chemo treatments, cancer cells appear to still be affected, but may be affected at
a dose of chemotherapy that minimizes toxic side effects.
As shown in the results above, NOB alone can slow the progression of proliferation,
but does not necessarily lead to apoptosis and leaves most of the cells morphologically
intact. To further define the effects NOB has on downstream signaling, the use of BRDU and
flow analysis would be beneficial in determining what stage of the cell cycle the cells are in
before and after treatment of NOB to see if NOB arrests the cell cycle in a particular stage of
the cell cycle. In addition, genomic approaches might be used to better understand which
ROR-BMAL1-regulated pathways get up- or down-regulated within AML cells.
Treating AML by targeting the clock in vivo could be potentially challenging for
several reasons. According to other sources of cancer biology and circadian pharmacological
manipulation (Lellupitiyage, 2020) each tissue has a different rhythmicity, but not only that,
each cell type within a system may have a different oscillation as well. As of now, there is
not much literature on the effects of NOB on AML specifically, but NOB has been known to
aid in cancer treatments since the 1990 (Bracke, 1990) and has shown promise in the
current treatment of different cancers such as breast cancer as shown in Dr. Seung-Hee
Yoo’s lab (Kim, 2022). Her lab exploits the findings from Dr. Chen’s lab (Chen, 2018) which
uses NOB to induce apoptosis to target the molecular clock by activating RORs in order to
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induce apoptosis in triple-negative breast cancer. While NOB did display anti-tumorigenic
effects in regards to cancer cell growth and migration, it was found that it was not due to
the modulation of the circadian clock at all but rather through activating ROR binding to the
ROR response elements of the IkBa promoter to inhibit proliferation. It did not restore
circadian rhythmicity of these naturally arrhythmic cells with or without NOB treatment,
suggesting that NOB may be affecting AML growth partially independent of BMAL1. Studies
using serum shock (which synchronizes cells in a dish) may be helpful in determining the
rhythmicity of AML cells, and to what extent it is altered in the context of AML treatment.
This distinction has been addressed in some other cancers. For example, in Lellupitiyage et
al. (Lellupitiyage, 2020) different clock profiles in various cancers and their varying effects in
conjunction with NOB were observed. Using a bone osteosarcoma line (U2OS) and two
breast cancer lines, MCF7 (known for its weak rhythmicity) and MDA-MB-231 (known for its
arrhythmicity) authors found that all three lines reacted differently to NOB and its
modulatory effects, suggesting that how a cell responds to NOB treatment may be based
upon its unique circadian molecular profile.
In preliminary studies (Mahan Lab, unpublished) our lab initially tried this treatment
of NOB combined with chemotherapeutic agent doxorubicin (DOX) with established cell line
MOLM13, which was chosen for its deadly fms-like tyrosine kinase receptor 3 (FLT-3)
mutation and is generally associated with poor patient survival. It was shown through
proliferation and western blot analysis that this cell line did best with both reagents and
showed a marked decrease in cell proliferation and an increase in p53 and cleaved caspase
three expression, indicating a drastic increase of cell apoptosis in the combined treatment
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conditions. However, since AML is heterogeneous in nature, testing other cell lines related
to AML progression and disease became imperative to see if a) their circadian molecular
signature was the same as that of MOLM13 and b) if the same doses of both NOB and DOX
would be as effective in guiding cells towards death (Fig.25).

Fig. 25

Fig. 25 Cleaved Caspase 3 and p53 expression in MOLM13 cells treated with different compounds. These
cells were subject to four conditions: NT (Non-treated), NOB (Nobiletin), DOX (Doxorubicin), and NOB + DOX.

Thus, our lab had chosen the cell lines of MOLM13, MV411, Kasumi-1, and THP-1 to
test this treatment and see if the apoptotic and proliferation effects would be the same. To
our surprise, there were some cell lines that were more sensitive to treatment than others
and one that had no response whatsoever. To investigate this perplexing matter further, a
western analysis of each cell line was performed and probed for RORɑ and BMAL1 as direct
and indirect outputs of RORɑ expression. What we found was varying molecular profiles for
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each cell line and that for this particular treatment to work, we had to optimize levels of
NOB and DNR to see the synergetic effects of cellular apoptosis within each line.
Although three out of four cell lines were responsive towards treatment and had low BMAL1
expression, the line of THP-1 (which is distinct in its endothelial origin compared to the
other AML lines) did not respond to NOB, potentially due to the fact that it displayed an
already high level of BMAL1 expression. We have previously observed that liver cancer lines
with high BMAL1 expression were also immune to the inhibitor effects of NOB on cell
growth (unpublished data). Though protein levels of RORɑ does not appear to change across
the cell lines, more analysis of ROR activity (i.e. nuclear localization, etc.) will be necessary
to fully understand why NOB has its specific effects. Other avenues of exploration regarding
ROR activity, the molecular clock, and apoptosis would be to look at alternative ROR
expressions such as RORƴ levels in conjunction with BMAL1 expressions and apoptotic
signaling as well as RORɑ knockdowns and overexpression to see how they affect BMAL1
output levels with and without NOB. Experiments investigating RORɑ, its influence on the
molecular clock, and links to apoptosis signaling are certainly a highly valuable area for
future studies.
Finally, I noticed that when passaging cell lines over a prolonged period of time
BMAL1 levels had changed with cell appearing to lose BMAL1 expression. This is an
additional variable to consider when testing the cell-specific effect of NOB. Nevertheless,
our data is promising, in that some AML lines, NOB in conjunction with DNR appears to
provide a beneficial effect over a single treatment.
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Concluding Remarks
In summary, my results support the idea that targeting the clock could be a tractable
solution for treating disease. In the context of metabolic disease, paradigms such as
restricted feeding and rhythmic energy expenditure may be means by which to increase the
amplitude of the clock in vivo and potentially to re-align clocks across the body. More
studies are required to determine the mechanisms by which exercise re-entrains the clock in
vivo, however targeted deletion of the clock in a tissue-specific manner would help
determine other organs potentially involved in re-entrainment.
In the context of cancer, targeting the clock may be an added mechanism by which
to achieve growth arrest. This is important for several reasons, one of which is reducing the
toxicity of existing drugs when used in combination. More work is needed to fully
understand the BMAL1-dependent vs. independent effects of NOB, but our preliminary data
suggests that this may be a promising solution for future therapy.
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Methods and Materials
All materials referenced will be found in Table 3.
Exercise as a Potential Therapeutic Strategy for Circadian Disruption in the Paraventricular
Nucleus
Animal Model
100-150 nl of AAV-GFP or AAV-CRE-GFP viral vectors were bilaterally injected with a
0.5ul syringe at a rate of 25-40nl per minute into the paraventricular nucleus (coordinates:
anteroposterior (AP): −0.5 to −0.6 mm; mediolateral (ML): ±0.2 mm; dorsoventral (DV):
−4.8 mm) of 12 (6 experimental AAV-CRE-GFP, 6 control AAV-GFP) male mice at 8 weeks old
and then placed under a two-week observation via infrared sensors to establish an
arrhythmic/rhythmic locomotor phenotype. Once established, animals were then exposed
to free-running conditions for 2 weeks via running wheel. After two weeks, the running
wheel was removed and animals were placed back onto IR for an additional month to assess
permeance of locomotor circadian rhythmicity recovery.

Data Collection
Activity bouts and wheel rotations were recorded using hardware and software (Vital
View) acquired from Starr Life Sciences and converted into a csv file. Data was then
analyzed using Actimetrics’ ClockLabs (version 6) Software and Microsoft Excel.
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Tissue Preparation and Preservation
Mice were injected with a concentration of 10µl/g of ketamine/xylazine cocktail (10
Ketamine:1 Xylazine) to slow the heart rate of each animal in preparation for the flushing
and cardiac profusion of each animal. They were then flushed with 30ml of 0.9% saline and
then fixed with 4% PFA. Brains were then extracted from the cranium and then placed in a
solution of 4% PFA for 24 hours. After 24 hours, brains were then placed in a solution of 10%
sucrose at 4°C for preservation. Coronal sections were then sliced at 30 microns per slice
using a freezing microtome and preserved in 0.1% Sodium Azide in PBS at 4°C. Tissue was
then mounted, dried, and cover slipped with 100µl of flouromount and sealed with clear
nail polish.

Imaging
Images of the PVN were then captured and stitched via Cytation5 at 4x magnification.

The Synergetic Effects of Nobiletin and Daunorubicin in AML Viability
Cell Culture
Kasumi-1, MV411, and THP-1 cell lines were acquired through ATCC. MOLM 13 cells
were gifted from the Chandra lab. All cell lines were cultured at 37°C with 5% CO2 in an
incubator. Cell lines Kasumi-1, MV411, THP-1, and MOLM13 were chosen to be
representative cell lines of AML. These lines were cultured as follows:
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Cell Line
MOLM 13

Characteristics
FLT-3 mutation, monocytes

Kasumi-1

TP53 mutation, myeloblasts

MV411

FLT-3 mutation,
macrophages/lymphoblasts

THP-1

Monocytes

Media
1640 RPMI (Hyclone), 5%
Pen/Strep (Gibco), 10% FBS
(Gibco)
1640 RPMI (ATCC), 5%
Pen/Strep (Gibco), 20% FBS
(Gibco)
IMDM (ATCC), 5%
Pen/Strep (Gibco), 10% FBS
(Gibco)
RPMI 1640 (Hyclone)
10% FBS
BME (0.05mM)

Table 1

Cell Treatment
Cell treatment was optimized using an IC50 approach via single doses of each
reagent using the following doses:
Cell Line
MOLM 13
Kasumi-1
MV411
THP-1

NOB Doses (µM)
5, 10, 25, 50
5, 10, 25, 50
5, 10, 25, 50
5, 10, 25, 50

DNR Doses (nM)
5, 10, 25, 50
5, 10, 25, 50
5, 10, 25, 50
5, 10, 25, 50

Table 2

Combination doses of NOB and DNR were chosen for each cell line to assess the synergetic
effects of both reagents together.

Cell Metabolic Assessment
An MTT Assay was used to assess metabolic health of cells at a time point of 0 hours,
24 hours, and 72 hours. Raw data was acquired through Cytation5 machine and background
subtracted (with background being the absorbance wavelength for vehicle-only treated
cells).
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Protein Expression Analysis
Harvesting and Quantifying Protein
All cell lines were grown at 5x106 per condition and harvested 72 hours later and
washed with 1x PBS. Supernatant was aspirated and the pellets were flash frozen in liquid
nitrogen and stored at -80°C for later protein extraction. Protein was extracted by pipetting
100-300µl of RIPA buffer with protein inhibitors and sonicating each sample for 30 secs.
Samples were then spun down at 10,000g for 10 minutes at 4°C. Supernatant was then
collected and frozen down at -80°C with 10µl-25µl taken for protein quantification via BCA
assay and read using the Cytation5 machine. Samples were then prepared with additional
RIPA buffer with protein inhibitors and 5x Laemmeli buffer to a concentration of 4µg of
protein/µl and a Laemmeli concentration of 1x.

Running and Transferring Western Blot
Thirty µg of protein from each condition and each cell line were boiled at 100°C for
10 minutes and then pipetted into each well of either 8% or 12% acrylamide gel and run at
70mV for 1.5-2 hours. The gel was then transferred over with 0.45um nitrocellulose and run
at 4°C for 1.5 hours at 100mV. After transferring, blot was immediately removed and stained
with Ponceau S to ensure correct protein transfer and then blocked with 5% non-fat milk
and 1x TBST for 1 hour at room temperature. Blot was then washed with 1x TBST for five
minutes in three rounds.
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Protein Detection
After washing, the blot was placed and sealed within a bag containing the primary
antibody of choice (BMAL1, RORɑ, Cleaved Caspase 3, Actin) at a dilution of 1:1,000 with 1x
TBST and then incubated overnight at 4°C. The blot was then removed and washed an
additional three times with 1x TBST for 5 minutes each and then blocked with the
corresponding secondary antibody (Anti-Mouse, Anti-Rabbit) at a dilution of 1:10,000 in 5%
blocking buffer for 1 hour at room temperature and then washed using the same procedure
mentioned above. One mL of developer was then used to develop the western and finally
detected with a Chemidoc Imaging System.

Protein Quantification
Protein was quantified using Image J software and then analyzed using Microsoft
Excel with proteins indicating BMAL1, RORɑ, and Cleaved Caspase 3 normalized to Actin to
achieve the final amount of protein per well.
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BMAL1 PVN KO Project
Animal Model
BMAL1 fl/fl animals (Jackson Laboratories, Strain#
007668)
AAV-CRE-GFP Virus (Core Facility, University of
Pennsylvania)
AAV-GFP Virus (Core Facility, University of
Pennsylvania)
Stereotaxic Injections via 0.5 µL syringe (Neuros
Model 7000.5 KH, point style 3)
Motorized Stereotaxic Injector (Quintessential
Stereotaxic Injector; Stoelting, Wood Dale, IL, USA)
Behavioral Recording and Analysis

AML Project
Cell Lines
Kasumi-1 (ATCC, Catalog #: CRL-2724)
MOLM13 (ATCC, Catalog #: ACC-554)
MV411 (ATCC, Catalog #: CRL-9591)
THP-1 (ATCC, Catalog #: TIB-202)
Cell Culture

UV Water Incubator, 37C, 5% CO2 (Panasonic)

Home Cage Infrared Sensors (Starr Life Sciences)

RPMI 1640 (ATCC, Catalog #: 30-2001)

Home Cage Running Wheel Rod Sensors (Starr Life
Sciences)
Home Cage Running Wheels (Starr Life Sciences)

IMDM (ATCC, Catalog #: 30-2005)

Vital View Software (Starr Life Sciences)

Fetal Bovine Serum (Gibco, Catalog #: 10082147)

Clock Labs (Actimetrics, version 6)
Imaging

Assessment of Cellular Metabolic Health
CellTiter 96® Non-Radioactive Cell Proliferation
Assay (MTT) (Promega, Catalog # G4000)

Cytation5 Machine (Biotek)
Tissue Preparation and Preservation
4% Paraformaldehyde (Fisher, Catalog #: J19943K2)

Trypan Blue (Sigma, Catalog #: T8154)
Treatments
Nobiletin (Cayman Chemicals, Catalog #: 15421)

Freezing Microtome (Leica SM 2010R)

Daunorubicin (MD Anderson Cancer Center
Pharmacy)
Doxorubicin (MD Anderson Cancer Center
Pharmacy)
Western Blot Detection
Clarity Western ECL Substrate (Bio-Rad, Catalog #:
1705061)
Chemidoc Imaging System (Bio-rad)
Antibodies
BMAL1 (Abcam, Catalog #: ab93806)
RORɑ (Abcam, Catalog #: ab70061)
Actin (Abcam, Catalog #: ab8227)
Cleaved Caspase 3 (Abcam, Catalog #: ab2302)

RPMI 1640 (Hyclone, Catalog #: SH30027.FS)

Table 3
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